Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: A rare case report and a review of the literature

RATIONALE: Fibrates are widely used to control hypertriglyceridemia and mixed dyslipidemia alone or in combination with statins. These drugs have rare, but severe and potentially vital adverse reactions of rhabdomyolysis and secondary acute renal failure (ARF). The objective of this article is to an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jingjing, Li, Dongfeng, Cheng, Qiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250032/
https://www.ncbi.nlm.nih.gov/pubmed/32481339
http://dx.doi.org/10.1097/MD.0000000000020390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250032/
https://www.ncbi.nlm.nih.gov/pubmed/32481339
http://dx.doi.org/10.1097/MD.0000000000020390

Ejemplares similares